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Abstract
Infected aortic aneurysms are surgical urgencies, requiring prompt management to avoid 
the development of catastrophic complications. Although traditional open surgery com-
posed of radical debridement and aortic reconstruction remains the gold-standard, many 
favorable results of the endovascular repair strategy have been reported. In this chapter, 
the etiology, bacteriology, clinical manifestation, and diagnostic criteria of infected aortic 
aneurysms will be discussed in detail at first, followed by a comprehensive review of 
both traditional open surgery and endovascular repair, based on current evidences and 
the authors’ institutional experience. Along with long-term oral antibiotic suppression 
and aggressive adjunctive procedures, endovascular repair for uncomplicated infected 
aortic aneurysms could be a definite treatment alternative to traditional open surgery in 
the endovascular era.
Keywords: infected aortic aneurysm, mycotic aortic aneurysm, antibiotic, aortic 
reconstruction, graft, endovascular aortic repair (EVAR), thoracic endovascular aortic 
repair (TEVAR)
1. Introduction
An infected aneurysm, commonly known as “mycotic aneurysm”, is an abnormal dilatation of 
the artery associated with an infectious process [1–5]. In 1885, Sir William Osler first used the 
term “mycotic aneurysm” to describe multiple bead-like aneurysms of the aortic arch, resulting 
from suppuration in vessel wall in one patient with infective endocarditis-related aortic valve 
vegetations [1]. Currently, mycotic aneurysm is widely accepted as synonymous with infected 
aneurysm, describing all kinds of infected aneurysms with different etiologies, but not only those 
caused by septic emboli from a cardiac origin [6]. Moreover, the majority of infected (mycotic) 
aneurysms is caused by bacteria, but not fungus [4]. In this chapter, we will discuss in detail 
and review the current literatures about infected aneurysm, and we will present the authors’ 
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institutional experience of infected aneurysms involving the aorta. Here, the term “infected aor-
tic aneurysm” instead of “mycotic aortic aneurysm” is used to prevent any misunderstanding.
Infected aortic aneurysms are generally surgical urgencies and comprise about 0.7–2.6% of all 
cases of aortic aneurysms [7–12]. The therapeutic considerations for infected aortic aneurysms 
include perioperative medical management (i.e., preoperative and postoperative antibiotic 
selection and course), timing and type of surgical procedures (traditional excision, debride-
ment, and reconstruction versus endovascular technique), and the necessity of adjunctive 
procedures [7–15]. Complications occasionally occur at the initial presentation, including 
massive exsanguination due to free rupture and the development of aneurysm-related fistu-
lations. Emergency operation is indispensable to salvage patients presenting with ruptured 
infected aortic aneurysms. Since the infectious process is usually not suppressed sufficiently 
even with proper antibiotic treatment course at the time of operation in these patients, the 
risk of postoperative persistent or even outbreak of infection is high [16–18]. Furthermore, the 
management of infected aortic aneurysms with aerodigestive communications is much more 
complex and remains inconclusive according to current evidence [18–23]. Thus, we will focus 
on uncomplicated infected aortic aneurysm in this chapter and propose strategies in manag-
ing this rare but severe disease in the endovascular era.
2. Etiology
Vascular infections with infected aneurysm formation generally have four types of etiolo-
gies according to Wilson’s classification [4, 6]: (1) aneurysm formation after microbial arteritis 
due to bacteremia or local infection invasion, (2) posttraumatic infected pseudoaneurysms, 
which were usually related to drug abuse in the past and with increased incidence with the 
use of endovascular procedures [24] (3) infection of preexisting aneurysms, and (4) infected 
(mycotic) aneurysm resulting from infective endocarditis-related septic emboli (as described 
by Sir Osler) [1]. The intima of the arterial structure is normally resistant to infection; however, 
the presence of injury or pathological change makes it vulnerable to microorganisms, espe-
cially Staphylococcus and Salmonella species [25, 26]. Untreated local infection or arteritis that is 
not suppressed by host immunity in the early stage could progress to abscess formation, vas-
cular perforation, and pseudoaneurysm formation. Furthermore, since the aorta is the most 
common site of atherosclerosis and aneurysm formation, infected aortic aneurysms usually 
result from bacteremic seeding to the diseased intima [6]. Rarely, infected aortic aneurysms 
secondary to an infectious process of adjacent structures, such as intraabdominal infection, 
empyema, mediastinitis, and vertebral osteomyelitis, have also been reported in Refs. [27–30].
Infected aortic aneurysms are also often developed in patients with various degrees of immu-
nosuppressed status, such as in diabetes mellitus, liver cirrhosis, end-stage renal disease, 
alcoholism, chronic glucocorticoid therapy, chemotherapy, posttransplantation immuno-
suppression, human immunodeficiency virus infection, and malignancy [10, 31–34]. These 
patients frequently present with atypical clinical features that make the diagnosis difficult 
and uncommonly delayed [10]. In our institutional experience, more than 70% of the operated 
patients with infected aortic aneurysm had impaired immunity due to the aforementioned 
conditions at the time of operation.
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3. Bacteriology
Overall, blood cultures were positive in more than half of patients with an infected aortic 
aneurysm, and intraoperative cultures could provide an even higher positive rate [5, 6, 35]. 
The causative microbiology of infected aortic aneurysms has changed after the advent of the 
antibiotic era and has a significant geographical difference. Before the popularized use of 
antibiotics, nonhemolytic Streptococcus species have once been the most common infectious 
organisms; subsequently, they account for less than 10% of infection cases after the advent of 
the antibiotic era [5, 36]. Currently, in Western countries, Staphylococcus species are generally 
the most common pathogens, accounting for 28–71% of cases based on published literatures 
[13, 37, 38]. It is also noteworthy that methicillin-resistant Staphylococcus aureus (MRSA) preva-
lence is continuously rising, and some reports indicated MRSA as the most dominant patho-
gen [39, 40]. Vancomycin-intermediate Staphylococcus aureus (VISA) has also been associated 
with infected aneurysms [41]. Gram-negative bacterium–related infected aortic aneurysms 
are less prevalent in Western countries than in East Asia, where Salmonella species are the most 
frequent Gram-negative bacteria causing aortic infections [11, 13, 38]. A diseased aorta, such 
as that with significant atherosclerotic change or preexisting aneurysm, is more vulnerable 
to Salmonella species [11]. In the literatures from Taiwan and in our institutional experience, 
Salmonella species account for 50–83% of cases of infected aortic aneurysms [11, 12, 14, 15].
Furthermore, the bacteriological spectrum may also be broader than that expected [37]. 
A recent report on endovascular treatment of infected aortic aneurysms from a European 
multicenter study revealed that 62% of the cases had a positive blood culture in which 20% 
was Staphylococcus species, 12% Salmonella species, and 11% Streptococcus species; approxi-
mately 19% were caused by other microorganisms [42]. A less common organism should 
always be considered in patients with infected aortic aneurysms, especially those in an 
immunosuppressed state [43]. Several Gram-negative bacterium–related infected aortic aneu-
rysms have been described, including Pseudomonas, Klebsiella, Escherichia coli, Campylobacter, 
Yersinia, Brucella, Haemophilus influenzae, Coxiella burnetii, Acinetobacter, Burkholderia pseudom-
allei, Campylobacter, Enterobacter cloacae, and Bacteroides fragilis [44–55]. A Gram-negative bac-
terium–related infection is usually associated with more aneurysm rupture and mortalities. 
Moreover, infected aortic aneurysms due to various fungal infections have also been reported, 
such as Candida, Cryptococcus, and Aspergillus [56–58]. Mycobacterium species could also result 
in infected aortic aneurysms [59, 60], while Bacillus Calmette-Guérin–related abdominal aorta 
infection has also been reported in Ref. [61].
4. Clinical manifestation and diagnostic criteria
Unlike superficial infected aneurysms, which normally presents with painful, pulsatile 
masses along with local or systemic infection features, the clinical manifestation of infected 
aortic aneurysms is often obscure. Patients with an infected thoracic aortic aneurysm may 
have deep and vague chest or upper back pain, while those with infected abdominal aortic 
aneurysm may have abdominal or lower back pain. Oftentimes, patients with infected aortic 
aneurysms may only present with fever of unknown origin, and a diagnosis is made typically 
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only after the aneurysms rupture or other complications develop. The structures adjacent to 
the infected aorta could be affected by direct bacterial invasion or a mass effect, resulting in 
gastrointestinal bleeding, dysphagia, hoarseness, hemoptysis, or the development of empy-
ema, arteriovenous fistula, osteomyelitis, or psoas abscess [10, 62, 63].
The diagnosis of an infected aortic aneurysm is made by imaging studies and evidence of 
infection. Computed tomography (CT) angiography, which has been the diagnostic modality 
employed, could timely and clearly provide information on the size and location of the aneu-
rysm as well as the anatomic relationship and possible involvement of the surrounding struc-
tures. The typical CT image suggestive of the presence of infectious process in the aorta shows 
irregular aortic wall, periaortic fat stranding, and presence of periaortic soft tissue mass, and 
fluid or air accumulation [64–66]. The aneurysm is usually saccular or multilobulated [65, 66]. 
Active extravasation of intravascular contrast medium is seen in ruptured aneurysm. A ret-
ropleural or retroperitoneal hematoma formation adjacent to the aneurysm can be observed 
if the aneurysm has a contained rupture. If contrast medium exposure is contraindicated, 
magnetic resonance angiography is the alternative choice of imaging study. As previously 
mentioned, it is not uncommon that no microorganism is identified in the blood sample from 
patients with infected aortic aneurysms; thus, a negative blood culture could not exclude the 
presence of infected aortic aneurysms.
Moreover, an infected aortic aneurysm should be distinguished from an inflammatory aor-
tic aneurysm, although not always easy especially considering that both have the following 
clinical symptoms: chest, abdominal, or back pain and low-grade fever. The presence of posi-
tive serial antinuclear antibody (ANA) and elevated IgG4 in patients with aortitis or aortic 
aneurysm could imply an underlying autoimmune disease [67, 68]. A “mantle sign” on CT 
imaging is suspicious of an inflammatory aortic aneurysm, which displays a thickened wall 
of the aortic aneurysm with periaortic inflammation and fibrosis [67].
5. Management
Infected aneurysms are clinically serious, and those involving the aorta could result in more 
significant morbidity and mortality despite prompt surgical interventions. With the high 
percentage of disease evolution to aneurysm rupture, antibiotic treatment alone results in 
extremely poor prognoses and should be only reserved for those with very high surgical risk 
and significant medical comorbidities [69]. Aggressive debridement with aortic reconstruc-
tion remains the gold-standard operative procedure; however, a complicated postoperative 
course generally could be anticipated [7]. Furthermore, for infected aneurysms affecting the 
thoracic aorta and aortic arch, the surgical procedure typically employs extracorporeal circu-
lation, cardiopulmonary bypass, and even a period of deep hypothermic circulatory arrest 
(DHCA), further increasing the operative risks. The feasibility of endovascular aortic repair 
(EVAR) for infected aortic aneurysms has been investigated in numerous studies, which in 
turn provided encouraging short-term results [18, 42, 70–74]. However, the long-term sur-
vival and late-onset complications, especially recurrent or persistent infections, are of greater 
concerns [74].
Aortic Aneurysm146
5.1. Antibiotic therapy
If an infected aortic aneurysm is suspected clinically, systemic broad-spectrum antibiotics 
should be initiated immediately before definite pathogen identification [69, 75]. Because of 
the high prevalence of Salmonella species infection in our country, we prefer administering 
ceftriaxone in every case of an infected aortic aneurysm if there is no contraindication [12, 
69, 71]. Once the culture and susceptibility results are available, antibiotics should be tailored 
accordingly. The minimum inhibitory concentration (MIC) of every susceptible antibiotic 
should be assessed and specialist consultation for infectious diseases should be liberal.
The optimal duration of antibiotic therapy both before and after surgical repair of an infected 
aortic aneurysm remains inconclusive. Generally, 4–8 weeks of systemic antibiotic course is 
accepted as the minimum treatment duration for infected aortic aneurysms [75]. The treatment 
effectiveness should be assessed, and the therapeutic course should be based on subsequent 
blood culture, serial examination of the inflammatory markers, and persistent evaluation of 
the clinical progress. Patients infected with highly drug-resistant organisms usually require 
a longer antibiotic therapy duration [76]. Furthermore, since the infected aorta is generally 
either reconstructed by prosthetic graft implantation or repaired with endovascular pros-
thesis deployment, suppressive oral antibiotics for a prolonged period following completed 
parenteral antibiotic therapy is often warranted [18, 69, 77]. Further details of the antibiotic 
therapy will be discussed in Sections 7.2 and 7.5.
5.2. Traditional open repair
Open surgical repair for an infected aortic aneurysm is composed of excision of the diseased 
aorta, debridement of the surrounding infected tissue, and immediate, and usually in situ, 
reconstruction of the aortic continuity. This operation technique for infected aortic aneurysms 
is generally consistent with that for noninfected aortic aneurysms. Patient positioning and 
surgical exposure depend on the anatomical and pathological conditions of the aneurysm, 
and the adjunctive monitoring or protective measures should be prudently executed based 
on the consensus between the surgeon and anesthesiologist. The operative considerations for 
infected aortic aneurysms with different anatomical locations are discussed below, and some 
representative completed reconstructions are illustrated in Figure 1.
5.2.1. Infected ascending aortic and aortic arch aneurysms
To replace an infected aneurysm of the ascending aorta and aortic arch, cardiopulmonary bypass 
is absolutely required, and an interval of DHCA is often necessary. Electroencephalographic 
monitoring or continuous recording of cerebral oxygen saturation is advisable. Intraoperative 
transesophageal echocardiography (TEE) is performed to assess cardiac function [78]. A full 
median sternotomy is the standard approach, and an extension to the neck or even a “trap-
door” incision is sometimes needed for better exposure of the distal arch and its branches. If 
aortic valve replacement is necessary for infective endocarditis or a concomitant pathology of 
the aortic valve, a composite graft replacement, or a separated replacement of the valve and 
aorta, is performed. Coronary arteries are reimplanted to the prosthetic graft with buttons of 
the aorta tissue (Button-Bentall procedure) if the aortic root is replaced [79, 80]. Occasionally, 
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Figure 1. Illustrations of different aortic reconstructions. (A) Ascending aorta and aortic root replacement, with a 
composite graft with a mechanical valve and reimplantation of the coronary arteries with buttons of the aorta tissue 
(Button-Bentall procedure). (B) Ascending aorta and aortic root replacement, with a composite graft with Cabrol 
modification. (C) Total arch replacement. (D) Descending thoracic aorta and proximal left subclavian artery replacement 
(semi-arch replacement), with reimplantation of the important spinal arteries (e.g., Adamkiewicz artery). (E) Juxta-
renal abdominal aorta replacement, with reimplantation of all visceral arteries. (F) Infra-renal abdominal aorta and iliac 
arteries replacement, with a bifurcated graft. Note the inferior mesenteric artery is not reimplanted. (G) Axillo-femoral 
bypass (extra-anatomical reconstruction), with aortic stumps closure. (H) Thoracic endovascular aortic repair (TEVAR), 
with chimney technique for left carotid artery debranching and a carotid-subclavian bypass for proximal sealing zone 
at zone I. (I) Endovascular aortic repair (EVAR), with chimney technique for left renal artery debranching and plug 
embolization for left internal iliac artery.
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no adequate healthy tissue for coronary artery reimplantation is found; a Cabrol technique 
or coronary artery bypass graft (CABG) can be used to reestablish the coronary flow [81, 82].
5.2.2. Infected thoracic and thoracoabdominal aortic aneurysms
Similar to noninfected thoracic and thoracoabdominal aortic aneurysms, an infected thoracic 
aortic aneurysm is repaired through a left thoracotomy with suitable intercostal spaces or a 
more extended thoracoabdominal incision [11, 77]. A simple clamp-and-sew technique, partial 
cardiopulmonary bypass, or left heart bypass can be chosen according to the characteristics of 
the aneurysm and the preference of the surgical team. If there is no space for proximal clamp-
ing, proximal anastomosis under a period of DHCA is necessary, and the use of intraoperative 
cerebral monitoring is also advisable. Cerebrospinal fluid (CSF) drainage should be routinely 
performed in all suitable patients, and evoked potential measurement should be considered [83, 
84]. If the operation is performed with simple aortic clamping, some adjunctive protective mea-
sures in addition to CSF drainage could be done, such as hypothermia (cool the patient to 34°C 
or slightly lower with low operation room temperature or cold intravenous fluid) and cold renal 
perfusion with crystalloid or blood [77, 83–85]. Of note, the adoption of clamp-and-sew tech-
nique during an infected thoracic aortic aneurysm repair should be carefully evaluated because 
excising the infected aorta and performing debridement often takes a considerably more time, 
which increases the distal ischemic time despite the  utilization of various protective strategies.
5.2.3. Infected abdominal (juxta-renal, supra-renal, and infra-renal) aortic aneurysms
Infected abdominal aortic aneurysms are generally repaired using a simple clamp-and-sew 
method through a median laparotomy, without extracorporeal circulatory support [9, 86]. 
Renal protective measures as previously described should be considered for those with a 
juxta-renal or supra-renal location. The involved visceral arteries are reimplanted to the graft 
[87]. Historically, aortic reconstruction with an autologous femoropopliteal venous graft has 
been advocated [88]. The time consumed and the morbidities caused by femoropopliteal vein 
harvest, along with the lack of availability of cryopreserved allografts, have urged more sur-
geons to prefer using prosthetic grafts, usually a Dacron graft, as alternatives [12, 14, 89–91]. 
An omental flap with preserved vascular supply is usually transposed to cover the graft and 
the anastomosis sites. Omental flaps separate the prosthesis from the surrounding contami-
nated structures and fill a dead space. The highly vascularized flap could also facilitate the 
systemic antibiotic delivery to the infected area [14].
5.2.4. Extra-anatomical reconstruction
To avoid prosthetic graft placement in the contaminated field and to restore the aortic flow 
with a remote route, extra-anatomical reconstruction is an attractive alternative to in situ 
reconstruction [9, 87, 92, 93]. Extra-anatomical reconstruction also includes excision of the 
infected aorta and debridement of the surrounding contaminated tissue, with aortic stump 
closure and aortic revascularization through a noninfected pathway. A unilateral or bilat-
eral axillo-femoral bypass after an infra-renal abdominal aorta excision is the most common 
 procedure. Extra-anatomical reconstruction has also been used for the repair of infected 
 aneurysm of the aortic arch [94]. Because of the residual aortic tissue fragility, a sustained risk 
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of aortic stump disruption exists [87, 95]. A two-layer closure is generally recommended, with 
coverage of a vascularized omental flap.
5.3. Endovascular technique
Since the first report by Semba et al. [96], an increasing number of investigations on endovas-
cular technique utilization in infected aortic aneurysm management, including one European 
multicenter study published in 2014 [15, 18, 42, 70–74, 97, 98], was noted. The general prin-
ciple and considerations of endovascular treatment for infected aortic aneurysms are identical 
to those for noninfected aortic aneurysms, including consideration of the characteristics of 
each device, arterial access route assessment (usually the iliac and femoral artery), anatomical 
characteristics of the aneurysm, and proximal and distal sealing zones.
A high-resolution multi-slice CT angiography providing essential information and a well-recon-
structed three-dimensional image is usually necessary for surgical planning. The endovascular 
procedure is performed in a hybrid operating room equipped with a fluoroscopic unit, where 
prompt conversion to traditional open surgery is possible. Depending on the patient’s situation, 
the procedure could be performed under general anesthesia, spinal anesthesia, or even local 
anesthesia. For patients with long-segment descending thoracic aorta coverage by the stent 
graft or, ideally for all patients undergoing thoracic endovascular aortic repair (TEVAR), CSF 
drainage should be performed for neuroprotection [99, 100]. Although controversial, the artery 
of Adamkiewicz, normally located between T8 and L2, should be preserved if possible [100]. 
If essential branches of the aorta are to be covered by stent grafts, revascularization by either a 
bypass surgery, open debranching, or endovascular debranching with a chimney technique or a 
fenestrated stent graft is necessary [101–105]. Adjunctive procedures, such as open debridement 
and percutaneous drainage, could be performed, based on the clinical judgment [74].
Although endovascular treatment for ascending aortic pathologies, including those with an 
infectious process, has been sporadically investigated [106–109], its use remains “off-label” 
for current commercially available aortic stent grafts. Further advances in the design of the 
devices and well-constructed studies are both necessary. Consequently, endovascular man-
agement for infected ascending aortic aneurysms is not discussed herein.
6. Outcomes
6.1. Antibiotic therapy alone
It was believed that patients with infected aortic aneurysms treated medically without under-
going aortic resection surviving to hospital discharge is almost impossible [38, 69]. In 2009, 
Hsu and colleagues from Taiwan reported the institutional experience of medical treatment 
of infected aortic aneurysms in high-risk patients, which revealed that the prognosis was not 
uniformly fatal [69]. The treatment strategy is composed of 6–8 weeks parenteral antibiotic 
administration during hospitalization, followed by lifelong oral antibiotics. Of the 22 patients 
(8 thoracic and 14 abdominal aortic aneurysms), the overall in-hospital mortality rate was 
50% and the 1-year event-free survival rate was 32%. Ruptured aneurysm was the major cause 
of death, accounting for 40.9% (9/22) of patients treated medically. Of note, two in-hospital 
deaths due to massive gastrointestinal tract bleeding, whose etiology was not mentioned, 
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were reported; aortoesophageal or aortoenteric fistulations could be the possible causes. The 
most common causative agent was the Salmonella species, which is responsible for 50% (11/22) 
of the cases, and the authors found that the prognosis of medically treated Salmonella-infected 
aneurysms was better than that of non-Salmonella infected cases. However, the prognosis of 
medically treated Salmonella-infected aortic aneurysm remains a subject of debate as most of 
the early reports from Western countries showed an extremely dismal result [38, 110, 111] 
(see more details in Section 7.1). The authors concluded that although the results of antibiotic 
treatment alone in patients with infected aortic aneurysm remained poor, it could still be an 
alternative treatment, especially in Salmonella-infected patients with very high surgical risks.
6.2. Traditional open repair
Due to the rarity of the disease, most reports regarding the surgical outcome of infected aortic 
aneurysms after traditional open repair have very heterogeneous case characteristics, with vari-
ous aortic segments involved and different methods for aortic reconstruction [9–14, 16, 17, 77, 
112–118]. Although admirable surgical outcomes have been reported, with both early and late 
mortalities as low as 5%, an early mortality rate of 5–40% and an at least 30% late mortality rate 
after open surgical repair of infected aortic aneurysms were demonstrated in most literatures 
[9–14, 16, 17, 77, 112–118]. Generally, the surgical outcomes for infected aneurysms with an infra-
renal location were better than those involving the aortic arch and descending thoracic, thora-
coabdominal, supra-renal, and juxta-renal aorta [11, 13, 16, 116]. An infected aneurysm of the 
ascending aorta is rare, and a successful surgical treatment has been reported in Refs. [119–123].
More than 50% of the patients undergoing open surgical repair of infected aortic aneurysms 
had early major complications, such as acute kidney injury, respiratory failure, and spinal 
ischemia. Late vascular complications, mostly a prosthetic graft infection, developed in up 
to 30% of the survivors [9–14, 16, 17, 77, 112–118]. Although the late outcomes are similar 
between in situ and extra-anatomical reconstruction, the latter is related to higher vascular 
complications, including aortic stump disruption (8–19%) and limb amputation (17–27%) 
 [91–95]. Re-infection of the prosthetic graft is also possible in patients undergoing extra- 
anatomical reconstruction [93, 95]. Nevertheless, extra-anatomical reconstruction is still a 
 reasonable option for patients who are unsuitable for in situ reconstruction.
6.3. Endovascular technique
The short-term advantage of endovascular infected aortic aneurysm repair has been gradually 
clarified, although most reports comprise small case numbers and limited follow-ups [15, 70–74, 
97, 98]. In 2007, Kan and colleagues reviewed English literatures investigating the efficiency of 
EVAR for infected aortic aneurysms [18]. The estimated overall 30-day survival rate was 89.6%, 
and the 2-year survival rate was 82.2% for the extracted 48 cases. Ruptured aneurysm, includ-
ing those complicated with aortic fistulations, and fever at the time of EVAR procedure were 
found to be the significant predictors of persistent infection. Several studies continuously dem-
onstrated that EVAR is a possible alternative procedure for infected aortic aneurysm patients 
with high surgical risks, with an early mortality rate less than 20%, which is comparable to that 
of traditional open repair. A poorer outcome was still evident in patients with aneurysm-related 
fistulation complication [71, 72, 124–127]. Persistent infection greatly contributed to both early 
and late mortalities; thus, adjunctive procedures to eliminate contamination and prolonged 
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antibiotic therapy duration after EVAR were usually advocated in the literatures [18, 72, 74] (see 
more details in Sections 7.4 and 7.5).
In 2014, Sörelius and colleagues conducted a European multicenter study, the largest retrospec-
tive study, to investigate the durability of EVAR for infected aortic aneurysms [42]. The 30-day, 
1-year, 5-year, and 10-year survival rate of the 123 patients identified was 91, 75, 55, and 41%, 
respectively. Of note, infected aortic aneurysms caused by non-Salmonella microorganisms were 
identified to have a worse long-term prognosis. Location of the aneurysm, presence of shock, or 
ruptured aneurysm at the time of operation showed no effects on the late outcome. Aneurysm-
related infection complications developed in 33 patients (26.83%) postoperatively, 23 of whom 
had an either early or late lethal outcome. The authors concluded that EVAR could be a feasible 
and durable choice for most patients with infected aortic aneurysms. Persistent or recurrent infec-
tion remained a great concern, necessitating a long-term antibiotic therapy and regular follow-up.
6.3.1. The institutional experience of endovascular management for uncomplicated infected aortic 
aneurysms from National Cheng Kung University Hospital, Tainan, Taiwan
National Cheng Kung University Hospital is a tertiary medical center in southern Taiwan and 
serves as a first-line hospital in Tainan City with an urban population of 1.8 million and also as 
a referral center for the whole southern Taiwan. As of the writing of this manuscript, a total of 
338 EVAR procedures (including TEVAR and hybrid procedures) for various purposes have 
been performed.
Since the first case of infected thoracic aortic aneurysm treated by TEVAR in March 2009, 
25 patients have undergone endovascular management for infected aortic aneurysms in our 
hospital. Six complicated cases were excluded from this study: two presented with aneurysm-
free rupture and hemorrhagic shock and received emergency EVAR and four were associ-
ated with aortoesophageal or aortobronchial fistulas. Finally, 19 cases, with a mean age of 
68.68 years (range: 43.94–83.65 years) and a mean follow-up of 20.54 months (range: 0.59–
85.13 months), were included. Several valuable preoperative and postoperative images from 
selected patients are shown in (Figures 2–5). There was one in-hospital mortality that had 
persistent periaortic graft infection despite continuous parenteral antibiotic treatment.
Figure 2. (A) Infected descending thoracic aortic aneurysm in a 70-year-old male patient (B) Oral antibiotic treatment 
continued for 1 year after TEVAR and CT angiography 2 years after TEVAR showed no residual aneurysm or periaortic 
infection. No adjunctive procedure was ever done for this patient.
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Figure 3. (A) Infected infra-renal abdominal aortic aneurysm in a 68-year-old diabetic male patient (B) CT angiography 
2 weeks after EVAR showed residual aneurysm but resolved periaortic inflammation. Percutaneous drainage of the 
aneurysm was done. (C) With long-term oral antibiotic suppression, the aneurysm disappeared completely on CT 
angiography 2 years later.
Figure 4. (A) Infected descending thoracic aortic aneurysm with periaortic foamy air collection (emphysematous aortitis) 
in an 83-year-old diabetic female patient. (B) Two weeks after TEVAR, there was still fluid accumulation around the stent 
graft and also abundant pleural effusion. Debridement through left mini-thoracotomy was done. (C) With long-term 
oral antibiotic suppression, the periaortic inflammation resolved 6 months later, despite this there was still some pleural 
effusion. (D) Gallium inflammation scan confirmed that there was no residual infection process.
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The patient refused open debridement and died 2 months after the EVAR procedure. Major 
postoperative early complications developed in nine patients (47.37%), including respira-
tory failure requiring tracheostomy in four, acute kidney injury in three, esophageal per-
foration in two, spinal cord ischemia in one, lower extremity ischemia in one, and hypoxic 
encephalopathy in one. The two cases developing esophageal perforation had no hemateme-
sis at initial presentation and their preoperative CT angiographies did not reveal any feature 
of aortoesophageal fistula. Persistent local infection or ischemic esophageal necrosis after 
TEVAR should be the cause resulting in esophageal perforation. Both these patients under-
went subsequent radical debridement and esophagectomy and were alive during the last 
follow-up.
Three late mortalities occurred, of which one was aneurysm-related mortality. The patient 
developed recurrent periaortic infection and subsequent aortoenteric fistula 2 years after the 
operation and died because of massive exsanguination. The estimated 30-day, 1-year, and 
5-year aneurysm-related survival rate was 100, 94.1, and 78.4%, respectively. No endoleak 
was detected by CT angiography beyond 30 days postoperatively. All patients with a follow-
up duration more than 6 months had disappearance of aneurysms along with complete reso-
lution of periaortic inflammation.
Long-term antibiotics were prescribed in nine patients (47.37%) in the study population. 
Adjunctive procedures to eliminate the infectious environment were performed in seven 
patients (36.84%), including open debridement in four (two patients also underwent concomi-
tant esophagectomy for postoperative esophageal perforation as previously mentioned) and 
percutaneous drainage in three patients. Due to the rarity of both early and late mortalities, 
the evaluation of the benefit of long antibiotic therapy duration and adjunctive procedures 
is challenging. For the same reason, analysis of other predictors of inferior early and late 
 outcomes was not performed.
Figure 5. (A) Infected descending thoracic aortic aneurysm caused by Salmonella enteritidis in a 60-year-old male patient. 
(B) The patient was complicated with persistent local infection and esophageal perforation 1 week after TEVAR. 
Debridement and esophagectomy by a video-assisted thoracic surgery (VATS) was done. (C) Oral antibiotics were kept 
for 1 year after hospital discharge and CT angiography 3 years after TEVAR showed completely resolved periaortic 
infection. Note the retrosternal gastric tube for esophagus reconstruction.
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7. Controversies
7.1. Salmonella-related versus non-Salmonella-related infected aortic aneurysm
Infected aortic aneurysms caused by Salmonella species were thought to be more virulent and 
tend to have a worse outcome, in view of the higher risk of early aneurysm rupture and 
prosthetic graft infection [110, 111, 128–132]. In 2010, Kan and colleagues compared the sur-
gical outcomes of 41 cases of infected aortic aneurysms identified from relevant literature 
reports and institute cases from 1990 to 2008 and found that Salmonella infection was a risk 
factor of postoperative aneurysm-related morbidity and mortality [71]; however, the type of 
 procedures (i.e., traditional open repair versus EVAR) was not.
With the advent of effective modern antibiotics, improved outcomes of Salmonella-related 
infected aortic aneurysms were reported in most of the recent literatures [12, 15, 118]. 
Salmonella infection prevalence in our institution is high; thus, we routinely prescribe ceftri-
axone as one of the empiric antibiotic agents (usually, vancomycin or oxacillin is added for 
a better coverage of Gram-positive microorganisms), provided that no contraindications are 
noted, once a diagnosis of an infected aortic aneurysm was made even before the availability 
of definite culture result. We also found a favorable outcome in patients with infected aortic 
aneurysms caused by Salmonella species in our institution. On the other hand, some studies 
identified a positive culture of non-Salmonella species as a predictor of a poorer outcome after 
both open surgery and endovascular procedures [17, 42, 77]. Thus, although still inconclusive, 
Salmonella infection should at least not be considered as a predictor of a worse outcome for 
infected aortic aneurysm.
7.2. Preoperative antibiotic course
Infected aortic aneurysms are surgical urgencies, and our mentors used to inculcate in us 
the cliché “avoid undue delay of operation.” Nevertheless, implanting a vascular prosthesis 
into a contaminated field in a patient with an active systemic infection might result in a cata-
strophic graft infection. Thus, the usual practice is to perform the operation after a period of 
parenteral antibiotic treatment if the patient’s condition permits [17, 18, 77, 116].
Hsu and colleagues retrospectively analyzed the clinical outcome of infected aortic aneurysms 
in National Taiwan University Hospital, Taipei, Taiwan, from 1995 to 2011 [118]. Of the 109 
patients identified, 85 underwent surgical intervention, including open repair in 77 and endo-
vascular repair in eight. The median preoperative antibiotic treatment duration was 8 days 
(interquartile range: 2–21 days). Ten deaths (early or late) directly related to  persistent/recur-
rent periaortic infection or prosthesis infection were reported. The authors found that shorter 
preoperative antibiotic treatment duration was associated with more aneurysm-related morali-
ties: a median preoperative antibiotic duration of 3 days (interquartile range: 0–7 days) in the 
deceased and 16 days (interquartile range: 3–26 days) in the survivors. In the systemic review 
of infected aortic aneurysms treated with EVAR by Kan et al. [18], 22 of the 48 patients received 
preoperative antibiotics for more than 1 week, and two patients had a postoperative persistent 
infection. In the univariate analysis, preoperative antibiotic treatment more than 1 week had a 
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protective effect against persistent infection; however, its benefit was not significant in the mul-
tivariate analysis. In fact, the decision on the preoperative antibiotic course is highly determined 
by other clinical conditions, which in turn could be confounding factors for worse prognosis. 
For example, the presence of aneurysm-related complications or profound sepsis would urge 
the surgeon to perform operation earlier, and both situations could affect the surgical outcome.
No study investigating the optimal surgical timing for infected aortic aneurysms after initial 
antibiotic treatment has so far been conducted; thus, the ideal preoperative antibiotic treat-
ment duration remains controversial. If the clinical condition permits, we favor performing 
operation (either open or endovascular repair) at least when fever subsides after adequate 
systemic parenteral antibiotic treatment or, more desirably, after a 7-day antibiotic course or 
confirmation of a negative culture result.
7.3. Choice of graft materials for in situ reconstruction
Numerous graft materials to reestablish the aortic continuity in situ are available, such as a 
prosthetic graft, an autologous venous graft, a cryopreserved allograft, and even an autolo-
gous or xenologous pericardial patch [91, 117, 133, 134]. An autologous venous graft or an 
allograft was considered to be more resistant to microorganisms than a prosthetic graft and 
thus used to be the preferred material for infected aorta reconstruction [88]. Despite the low 
reinfection rate and good durability of the autologous femoropopliteal venous grafts, consid-
erable major morbidities are associated with femoropopliteal vein harvest, including com-
partment syndrome requiring fasciotomy in 12% and chronic venous insufficiency in 15% of 
the patients [89]. The availability of cryopreserved allografts in Taiwan and most countries in 
East Asia is limited [14, 117].
The reinfection rate after in situ reconstruction with prosthetic grafts for infected aortic aneu-
rysms, which was as high as 20% in early reports [135], has decreased significantly recently. 
Several studies in Taiwan, including our institutional experience, have demonstrated a graft 
infection rate of 8.0–10.4% after in situ prosthetic graft replacement for infected aortic aneu-
rysms [11, 12, 113–116, 118]. In a more recent study investigating the outcomes of open repair of 
infected descending thoracic and thoracoabdominal aortic aneurysms by Lau et al., no postoper-
ative graft infection occurred in 14 patients who had in situ prosthetic graft reconstruction [77].
In 2011, Bisdas et al. analyzed the prognosis of cryopreserved allografts and silver-coated 
Dacron grafts for abdominal aortic infections with positive intraoperative culture and found 
comparable short-term and mid-term survival rates [91]. None of the 22 patients in the 
 cryopreserved allograft group developed graft infection, while two of the 11 patients in the 
silver-coated Dacron graft group had an ongoing or recurrent infection. Of interest, the costs of 
therapy were significantly higher for cryopreserved allografts. Moreover, other studies have 
revealed favorable results of in situ antibiotic-bonded prosthetic graft replacement for infected 
aortic aneurysms [117, 136]; nevertheless, its effectiveness still requires further investigations.
7.4. Adjunctive procedures after the initial EVAR
The major concern of endovascular treatment for infected aortic aneurysms is the residual 
infectious environment surrounding the deployed device. Additional surgical procedures, 
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such as debridement of the infected tissue and drainage of the abscess, could aid in eradicat-
ing the infection and thus improve the outcome [18, 74, 137]. Furthermore, additional culture 
information could be obtained through the specimen derived from these procedures.
In our systemic review, performing adjunctive procedures after EVAR serves as a protective 
factor against persistent infection in the univariate analysis; however, the benefit was insig-
nificant in the multivariate analysis [18]. In 2011, Kritpracha and colleagues published their 
institutional experience of endovascular therapy for infected aortic aneurysms and showed 
an impressive mid-term outcome for those without an aortic fistulation [72]. They routinely 
prescribed lifelong antibiotics to the patients, and no adjunctive procedure was conducted. 
During a mean follow-up of 22 months, no late mortality or aneurysm-related complication 
in the 15 patients surviving to hospital discharge was reported. Complete resolution of peri-
aortic inflammation and shrinkage of the aneurysms were observed in most of the patients 
starting at the 6-month follow-up. The authors thus suggested that aggressive debridement 
of the infected tissue may not be necessary for those with uncomplicated infected aortic 
aneurysms.
Determining the effectiveness of each adjunctive procedure is also difficult, and the selec-
tion should be individualized. We prefer performing CT-guided drainage if the patient 
remains febrile or unsterilized blood sample persists after EVAR provided that the periaor-
tic abscess has been adequately liquefied. Irrigation of the abscess cavity with antibiotics or 
disinfectants could also be performed [74]. A more extensive open debridement is gener-
ally reserved for those with an unsatisfactory response to the aforementioned less-invasive 
measures.
7.5. Postoperative antibiotic course
No consensus on the optimal postoperative antibiotic treatment duration is available. For 
other cardiovascular infections, at least 4–8 weeks of parenteral antibiotic therapy after sur-
gical intervention is generally accepted, and the course should be carefully tailored accord-
ing to the clinical and laboratory parameters [75]. Several authors have advocated long-term 
oral antibiotic suppression after hospital discharge for all operated patients, especially those 
who underwent endovascular repair [9, 10, 15, 42, 77]. However, drug adherence is typically 
less than ideal, mainly because of the development of antibiotic-related adverse reactions or 
patient noncompliance.
In the early institutional experience of in situ prosthetic graft replacement for infected 
abdominal aortic aneurysms published in 2003, Luo and colleagues found that oral antibiotic 
 suppression, prolonged or not, was not related to the development of late graft infection [12]. 
Thereafter, we did not routinely prescribe oral antibiotics to patients who had received open 
repair at hospital discharge. Following our strategy of both pre- and postoperative antibiotic 
treatment, as previously mentioned, only two patients have developed late graft infections 
after in situ prosthetic graft replacement for infected abdominal aortic aneurysms [14].
Moreover, in our practice, long-term oral antibiotic suppression is generally planned at hos-
pital discharge for those who had endovascular repair for infected aortic aneurysms [15]. The 
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surgeon’s decision on antibiotic treatment termination, provided that no residual infection 
based on clinical, imaging, and laboratory evidence is noted, is individualized. Of 18 hospi-
tal survivors with uncomplicated infected aortic aneurysms treated with EVAR, along with 
long-term oral antibiotic suppression and aggressive adjunctive procedures, only one patient 
(5.6%) developed a late aneurysm-related complication (i.e., recurrent periaortic infection 
complicated with aortoenteric fistula).
8. Epilogue
Based on current evidence and our institutional experience, we have introduced and adopted 
the following therapeutic strategy for infected aortic aneurysms in the endovascular era:
1. Open repair through the excision of the infected aorta and radical debridement of the sur-
rounding contaminated structure with immediate aortic reconstruction remains the gold 
standard. Although a higher reinfection rate is theoretically possible, in situ reconstruction 
with a prosthetic graft, along with adequate perioperative antibiotic course, is a safe and 
durable choice and could be applied in most patients. Long-term oral antibiotic suppres-
sion is not necessary provided that no evidence of ongoing infection after completion of 
parenteral antibiotic therapy is found.
2. For uncomplicated infected aortic aneurysms, endovascular treatment can be a reasonable 
alternative, especially for patients with significant comorbidities. If clinically feasible, an 
EVAR procedure can be performed after controlling overt infection, usually at least 3–7 
days after parenteral broad-spectrum antibiotic treatment. The postoperative parenteral 
antibiotic treatment duration is at least 4–8 weeks. Long-term or even lifelong oral antibi-
otic suppression is recommended, and adjunctive procedures to eliminate the infectious 
environment are also considered. With the adoption of the abovementioned therapeutic 
strategies, the role of EVAR for uncomplicated infected aortic aneurysms has evolved from 
a temporary palliation to a reliable definite therapy.
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